[ Contents | Search | Next | Previous | Up ]
From: Ora McCreary
Date: 13 Oct 2010
Time: 12:07:44 -0500
Remote Name: 64.95.16.243
Dr. Lavid - Thank you for your response. You wrote, "If and when a more tolerable fluency-inducing medication becomes available, it will be a treatment option for those who stutter." Your comments seem to suggest that you may believe that it's premature for the existing drugs to be used for therapy for stuttering, and that we'd be better to wait for more specific treatments, with a better risk profile. I wonder if you can offer any information or opinions on the drug therapies that are already being offered by Gerald Maguire and his colleagues at their center at UC Irvine - which of course do include drugs with the adverse effects you've mentioned. (Perhaps others are doing similar things, but this is the group I've heard of.) Do you know what sort of success they've had in treating stutterers with the currently available drugs? Have they been able to navigate successfully between satisfactory therapeutic results and the adverse effects? Thank you.